Tg Therapeutics TGTX
NASDAQ TGTX
$54.29 +0.67 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Net Equity Issued and Repurchased (2011 - 2026)

Updated

Tg Therapeutics (TGTX) posted Net Equity Issued and Repurchased of $85,000 for Q2 2026, down 80.3% from $432,000 a year earlier and down 88.9% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Tg Therapeutics was $1.91 million, up 56.0% year-over-year; for FY2025, it was $1.51 million, up 65.3% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 59.4% (FY2020 to FY2025).
  • In prior years, Tg Therapeutics' Net Equity Issued and Repurchased was $914,000 in FY2024 (-98.0%), $46.3 million in FY2023, $584,000 in FY2022 (-73.7%) and $2.22 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last four quarters, with growth averaging 83.8%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2022, with growth of 450.0%; the weakest was Q2 2024, with a decline of 99.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Tg Therapeutics 8.21 Bn 7.60 Bn 199.14 Mn 85,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85,000.00
Mar 31, 2026 763,000.00
Dec 31, 2025 1.06 Mn
Jun 30, 2025 432,000.00
Mar 31, 2025 21,000.00
Dec 31, 2024 570,000.00
Sep 30, 2024 199,000.00
Jun 30, 2024 135,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 -1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 45.93 Mn
Mar 31, 2023 363,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 275,000.00
Jun 30, 2022 135,000.00
Mar 31, 2022 125,000.00
Dec 31, 2021 2.00 Mn
Sep 30, 2021 50,000.00
Jun 30, 2021 38,000.00
API Access

Tg Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TGTX&period=max&api_key=YOUR_API_KEY